<SEC-DOCUMENT>0001178913-21-001175.txt : 20210325
<SEC-HEADER>0001178913-21-001175.hdr.sgml : 20210325
<ACCEPTANCE-DATETIME>20210325093041
ACCESSION NUMBER:		0001178913-21-001175
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20210325
DATE AS OF CHANGE:		20210325
EFFECTIVENESS DATE:		20210325

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RedHill Biopharma Ltd.
		CENTRAL INDEX KEY:			0001553846
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-254692
		FILM NUMBER:		21770367

	BUSINESS ADDRESS:	
		STREET 1:		21 HA'ARBA'A STREET
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			64739
		BUSINESS PHONE:		972-3-541-3131

	MAIL ADDRESS:	
		STREET 1:		21 HA'ARBA'A STREET
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			64739
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>zk2125809.htm
<DESCRIPTION>S-8
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using EDGARfilings PROfile 7.4.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; text-indent: 36pt; line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">Registration No.
      ______________</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25;">As filed with the Securities and Exchange Commission on March 25, 2021</div>
    <div style="text-align: center; line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">UNITED STATES</font><br>
      <font style="font-size: 14pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</font><br>
      WASHINGTON, DC 20549</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">
      <hr align="center" style="height: 1px; width: 8%; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;">FORM S-8</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">REGISTRATION STATEMENT<br>
      UNDER<br>
      THE SECURITIES ACT OF 1933</div>
    <div style="line-height: 1.25;">
      <hr align="center" style="height: 1px; width: 8%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br>
    </div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-size: 16pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;">REDHILL BIOPHARMA LTD.</font><br>
      (Exact name of registrant as specified in its charter)</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="z0fe0a77e68854b44a17200db08203d9f">

          <tr>
            <td style="width: 50%;">
              <div>
                <div style="text-align: center;"><font style="font-family: 'Times New Roman',Times,serif;">Israel</font></div>
                <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(State or other jurisdiction of </div>
                <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">incorporation or organization)</div>
              </div>
            </td>
            <td style="width: 50%; text-align: center; vertical-align: top;">
              <div><font style="font-family: 'Times New Roman',Times,serif;">Not Applicable</font></div>
              <div><font style="font-family: 'Times New Roman',Times,serif;"></font><font style="font-family: 'Times New Roman',Times,serif;">(I.R.S. Employer Identification No.)</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: center; line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">21 Ha'arba'a Street</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Tel Aviv 6473921,</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Israel</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">(Address of Principal Executive Offices) (Zip Code)<br>
      <br>
      <font style="font-weight: bold;">Redhill Biopharma Ltd. Amended and Restated Award Plan (2010)<br>
      </font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">(Full title of the plan)<br>
      </font><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">RedHill Biopharma Inc.<br>
      8045 Arco Corporate Drive, Suite 100<br>
      Raleigh, NC&#160; 27617<br>
      (984) 444-7010</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25;">&#160;(Name and address of agent for service)</div>
    <div style="text-align: center; line-height: 1.25;">(Telephone number, including area code, of agent for service)<br>
      <br>
      <font style="font-style: italic;">Copy to:</font><br>
      <font style="font-weight: bold;">Perry Wildes, Adv.</font><br>
      <font style="font-weight: bold;">Gross &amp; Co.</font><br>
      <font style="font-weight: bold;">One Azrieli Center</font><br>
      <font style="font-weight: bold;">Tel Aviv 6701101, Israel</font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.&#160; See the definitions of "large accelerated
      filer", "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="zbd0a9fd9237843fbbf4157761bd7cb4d">

          <tr>
            <td style="width: 50%; text-align: left; vertical-align: top;">
              <div><font style="font-family: 'Times New Roman',Times,serif;">Large Accelerated Filer &#9744;</font></div>
              <div><font style="font-family: 'Times New Roman',Times,serif;"> <br>
                </font></div>
              <div>
                <div style="text-align: justify; line-height: 1.25;">Non-Accelerated Filer &#9744; (Do not check if a smaller reporting company)<br>
                </div>
                <font style="font-family: 'Times New Roman',Times,serif;"> </font></div>
            </td>
            <td style="width: 50.00%;">
              <div>Accelerated Filer &#9746;</div>
              <div> <br>
              </div>
              <div>Smaller reporting company &#9744; </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: justify; line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="text-align: justify; line-height: 1.25;"><br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">CALCULATION OF REGISTRATION FEE</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z43a7e7886f454446a382e78299d6f5a9">

        <tr>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="line-height: 1.25; font-weight: bold;">Title of securities to be registered</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">Amount to be</font><br>
              <font style="font-weight: bold;">registered</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Proposed maximum<br>
              offering price<br>
              per share</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Proposed maximum<br>
              aggregate offering<br>
              price</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Amount of<br>
              registration<br>
              fee</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; padding-bottom: 2px;" colspan="1">&#160;</td>
        </tr>
        <tr>
          <td valign="bottom" style="vertical-align: top; width: 52%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
            <div style="line-height: 1.25;">Ordinary Shares, par value NIS 0.01 per share, deposited as American Depositary Shares represented by American Depositary Receipts <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="line-height: 1.25;">16,526,070</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup>&#160;</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="line-height: 1.25;">0.751</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">
            <div style="line-height: 1.25;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">4)</sup>&#160;</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="line-height: 1.25;">12,411,079</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
          <td valign="bottom" style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="line-height: 1.25;">$</div>
          </td>
          <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);" colspan="1">
            <div style="line-height: 1.25;">1,354.05</div>
          </td>
          <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: rgb(204, 238, 255);" colspan="1">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">(1)&#160;&#160;&#160; American Depositary Shares (&#8220;ADSs&#8221;), evidenced by American Depositary Receipts, issuable upon deposit of the ordinary shares registered hereby, par value NIS 0.01 per share (&#8220;Ordinary
      Shares&#8221;), of Redhill Biopharma Ltd. (the &#8220;Company&#8221;) are registered on a separate registration statement on Form F-6 (File No. 333-185302). Each ADS represents ten (10) Ordinary Shares.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;">(2)&#160;&#160;&#160;&#160; Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this registration statement shall also cover any additional Ordinary Shares that become issuable
      under the Redhill Biopharma Ltd. Amended and Restated Award Plan, as amended (the "Plan") by reason of any stock dividend, stock split, or other similar transaction.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;">(3)&#160; &#160;&#160; Represents the number of additional Ordinary Shares reserved for future issuance under the Plan.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;">(4)&#160; &#160; Estimated solely for purposes of calculating the registration fee pursuant to Rules 457(c) and 457(h) under the Securities Act, and based on the average of the high and low prices of the
      Company's ADSs reported on the NASDAQ Global Market on March 23, 2021.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">2</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">STATEMENT PURSUANT TO GENERAL INSTRUCTION E</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">OF FORM S-8</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; margin-right: 0.2pt; line-height: 1.25; font-weight: bold;">EXPLANATORY NOTE</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; margin-right: 0.2pt; line-height: 1.25;">This Registration Statement on Form S-8 (this &#8220;Registration Statement&#8221;) registers an additional 16,526,070 ordinary shares, par value NIS 0.01 per share,
      deposited as American Depositary Shares represented by American Depositary Receipts, of Redhill Biopharma Ltd. (the &#8220;Company&#8221;), which may be issued under the&#160;Redhill Biopharma Ltd. Amended and Restated Award Plan (the "Plan").</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">PART I</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">ITEM 1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;PLAN INFORMATION.*</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">ITEM 2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;REGISTRANT INFORMATION AND EMPLOYEE PLAN ANNUAL INFORMATION. *</div>
    <div style="text-align: justify; line-height: 1.25;">___________________</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">* Information required by Part I to be contained in the Section 10(a) prospectus is omitted from this registration statement in accordance with Rule 428 under the Securities Act of 1933, as amended,
      or the Securities Act, and the Introductory Note to Part I of Form S-8.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;PART II</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">ITEM 3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;INCORPORATION OF DOCUMENTS BY REFERENCE</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; line-height: 1.25;">The following documents filed with or furnished to the Securities and Exchange Commission (the &#8220;<u>Commission</u>&#8221;) by RedHill Biopharma Ltd., a company organized under the laws of
      Israel (the &#8220;<u>Company</u>&#8221; or the &#8220;<u>Registrant</u>&#8221;), are incorporated herein by reference and made a part hereof:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zc7a63fdebd204768a3dd1ddefb79470d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 6pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="margin-left: 18pt; line-height: 1.25;">(a)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">the Company&#8217;s Annual Report on Form 20-F for the year ended December 31, 2020, filed with the Commission on March 18, 2021;</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z59e9fc93001642ad886360c494f7e5d1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 6pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="margin-left: 18pt; line-height: 1.25;">(b)</div>
              <div style="line-height: 1.25">&#160;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">The Company's report on Form 6-K furnished to the Commission on January 6, 2021, January 11, 2021 (two reports), January 14 (two reports), January 28, 2021, January 29, 2021, February 2,
                2021, and February 17, 2021, February 18, 2021, February 23, 2021, March 4, 2021, March 22, 2021 and March 25, 2021; and</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z150d563201fb452ea26a8f4ac379ecaa" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-bottom: 6pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="margin-left: 18pt; line-height: 1.25;">(c)</div>
              <div style="line-height: 1.25">&#160;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">the description of the Company&#8217;s ordinary shares, par value NIS 0.01 per share, included in Item 10B of the Registration Statement on Form 20-F filed with the Commission on December 26,
                2012, including any subsequent amendment or any report filed for purposes of updating such description.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: justify; text-indent: 27pt; line-height: 1.25;">All documents or reports subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the "<u>Exchange Act</u>"),



      and to the extent designated therein, certain reports on Form 6-K, furnished by the Company, after the date of this Registration Statement and prior to the filing of a post-effective amendment which indicates that all securities offered hereby have
      been sold or which deregisters all securities offered hereby then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of filing of such documents or reports. Any
      statement in a document or report incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for the purposes of this Registration Statement to the extent that a statement contained herein or in any
      other subsequently filed document or report which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to
      constitute a part of this Registration Statement.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">3</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">ITEM 4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;DESCRIPTION OF SECURITIES</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 49.85pt; line-height: 1.25;">Not applicable.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">ITEM 5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;INTERESTS OF NAMED EXPERTS AND COUNSEL</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-indent: 49.85pt; line-height: 1.25;">Not applicable.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">ITEM 6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;INDEMNIFICATION OF DIRECTORS AND OFFICERS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Exemption, Insurance, and Indemnification of Directors and Officers</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Exemption of Officers and Directors</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Under the Israeli Companies Law, 1999, or the Israeli Companies Law, a company may not exempt an officer or director from liability with respect to a breach of his duty of loyalty, but may exempt in
      advance an officer or director from liability to the company, in whole or in part, with respect to a breach of his duty of care, except in connection with a prohibited distribution made by the company, if so provided in its articles of association.
      Our articles of association provide for this exemption from liability for our directors and officers.</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Directors&#8217; and Officers&#8217; Insurance</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Israeli Companies Law and our articles of association provide that, subject to the provisions of the Israeli Companies Law, we may obtain insurance for our directors and officers for any
      liability stemming from any act performed by an officer or director in his capacity as an officer or director, as the case may be with respect to any of the following:</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">
      <div style="line-height: 1.25;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 2.41%; vertical-align: middle;">&#160;</td>
              <td style="width: 2.28%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
                <div>&#8226;</div>
              </td>
              <td style="width: 0.13%; vertical-align: middle;">&#160;</td>
              <td rowspan="1" style="width: 50.28%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">
                  <div style="line-height: 1.25;">
                    <div style="line-height: 1.25;">a breach of such officer&#8217;s or director&#8217;s duty of care to us or to another person;</div>
                  </div>
                </div>
                <div style="text-align: justify; line-height: 1.25;"> <br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 2.41%; vertical-align: middle;">&#160;</td>
              <td style="width: 2.28%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
                <div>&#8226;</div>
              </td>
              <td style="width: 0.13%; vertical-align: middle;">&#160;</td>
              <td rowspan="1" style="width: 50.28%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">
                  <div style="line-height: 1.25;">
                    <div style="line-height: 1.25;">a breach of such officer&#8217;s or director&#8217;s duty of loyalty to us, provided that such officer or director acted in good faith and had reasonable cause to assume that his act would not prejudice our
                      interests;</div>
                  </div>
                </div>
                <div style="text-align: justify; line-height: 1.25;"> <br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 2.41%; vertical-align: middle;">&#160;</td>
              <td style="width: 2.28%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
                <div>&#8226;</div>
              </td>
              <td style="width: 0.13%; vertical-align: middle;">&#160;</td>
              <td style="width: 95.17%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">
                  <div style="line-height: 1.25;">a financial liability imposed upon such officer or director in favor of another person;</div>
                </div>
                <div style="text-align: justify; line-height: 1.25;"> <br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 2.41%; vertical-align: middle;">&#160;</td>
              <td style="width: 2.28%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
                <div>&#8226;</div>
              </td>
              <td style="width: 0.13%; vertical-align: middle;">&#160;</td>
              <td style="width: 95.17%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">
                  <div style="line-height: 1.25;">
                    <div style="line-height: 1.25;">financial liability imposed on the officer or director for payment to persons or entities harmed as a result of violations in administrative proceedings as&#160;described in Section 52(54)(a)(1)(a) of the
                      Israeli Securities Law (the &#8220;Party Harmed by the Breach&#8221;);</div>
                  </div>
                </div>
              </td>
            </tr>

        </table>
      </div>
      <div style="line-height: 1.25;">&#160;
        <div style="line-height: 1.25;">
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 2.41%; vertical-align: middle;">&#160;</td>
                <td style="width: 2.28%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
                  <div>&#8226;</div>
                </td>
                <td style="width: 0.13%; vertical-align: middle;">&#160;</td>
                <td rowspan="1" style="width: 50.28%; vertical-align: top;">
                  <div style="text-align: justify; line-height: 1.25;">
                    <div style="line-height: 1.25;">
                      <div style="line-height: 1.25;">
                        <div style="line-height: 1.25;">expenses incurred by such officer or director in connection with an administrative proceeding conducted in this matter, including reasonable litigation expenses, including legal fees; or</div>
                      </div>
                    </div>
                  </div>
                  <div style="text-align: justify; line-height: 1.25;"> <br>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 2.41%; vertical-align: middle;">&#160;</td>
                <td style="width: 2.28%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
                  <div>&#8226;</div>
                </td>
                <td style="width: 0.13%; vertical-align: middle;">&#160;</td>
                <td rowspan="1" style="width: 50.28%; vertical-align: top;">
                  <div style="text-align: justify; line-height: 1.25;">
                    <div style="line-height: 1.25;">
                      <div style="line-height: 1.25;">
                        <div style="line-height: 1.25;">a breach of any duty or any other obligation, to the extent insurance may be permitted by law.</div>
                      </div>
                    </div>
                  </div>
                </td>
              </tr>
              <tr>
                <td style="width: 2.41%; vertical-align: middle;">&#160;</td>
                <td style="width: 2.28%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
                  <div><br>
                  </div>
                </td>
                <td style="width: 0.13%; vertical-align: middle;">&#160;</td>
                <td style="width: 95.17%; vertical-align: top;">
                  <div style="text-align: justify; line-height: 1.25;">
                    <div style="line-height: 1.25;"><br>
                    </div>
                  </div>
                </td>
              </tr>

          </table>
        </div>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">Pursuant to the Compensation Policy for directors and officers (the &#8220;Compensation Plan&#8221;), we may obtain a directors' and officers' liability insurance policy, which would apply to our and/or our
      subsidiaries' directors and officers, as they may be, from time to time,&#160;subject to the following terms and conditions: (a) the total insurance coverage under the insurance policy may not exceed $100 million; and (b) the purchase of such policy shall
      be approved by the Compensation Committee (and, if required by law, by the Board) which shall determine that such policy reflects the current market conditions, and it shall not materially affect the Company's profitability, assets or liabilities. In
      addition, pursuant to our Compensation Policy, should we sell our operations (in whole or in part) or in case of merger, spin-off or any other significant business combination involving us or part or all of our assets, we &#160; may obtain a director&#8217;s
      and officers&#8217; liability insurance policy (run-off) for our directors and officers in office with regard to the relevant operations, subject to the following terms and conditions: (a) the insurance term may not exceed seven years; (b) the coverage
      amount may not exceed $100 million; and (c) the purchase of such policy shall be approved by the Compensation Committee (and, if required by law, by the Board) which shall determine that such policy reflects the current market conditions, and it
      shall not materially affect the Company's profitability, assets or liabilities. The Compensation Policy is in effect for three years from the 2019 annual general meeting.</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">4</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Pursuant to the foregoing approvals, we carry directors' and officers' liability insurance. This insurance is renewed on an annual basis.</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Indemnification of Officers and Directors</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Israeli Companies Law provides that a company may indemnify an officer or director for payments or expenses associated with acts performed in his capacity as an officer or director of the
      company, provided the company&#8217;s articles of association include the following provisions with respect to indemnification:</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: justify; line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 2.41%; vertical-align: middle;">&#160;</td>
            <td style="width: 2.28%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div>&#8226;</div>
            </td>
            <td style="width: 0.13%; vertical-align: middle;">&#160;</td>
            <td rowspan="1" style="width: 50.28%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">
                <div style="line-height: 1.25;">a provision authorizing the company to indemnify an officer or director for future events with respect to a monetary liability imposed on him in favor of another person pursuant to a judgment (including a
                  judgment given in a settlement or an arbitrator&#8217;s award approved by the court), so long as such indemnification is limited to types of events which, in the board of directors&#8217; opinion, are foreseeable at the time of granting the indemnity
                  undertaking given the company&#8217;s actual business, and in such amount or standard as the board of directors deems reasonable under the circumstances. Such undertaking must specify the events that, in the board of directors&#8217; opinion, are
                  foreseeable in view of the company&#8217;s actual business at the time of the undertaking and the amount or the standards that the board of directors deemed reasonable at the time;</div>
              </div>
              <div style="text-align: justify; line-height: 1.25;"> <br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 2.41%; vertical-align: middle;">&#160;</td>
            <td style="width: 2.28%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div>&#8226;</div>
            </td>
            <td style="width: 0.13%; vertical-align: middle;">&#160;</td>
            <td rowspan="1" style="width: 50.28%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">
                <div style="line-height: 1.25;">a provision authorizing the company to indemnify an officer or director for future events with respect to reasonable litigation expenses, including counsel fees, incurred by an officer or director in which he
                  is ordered to pay by a court, in proceedings that the company institutes against him or instituted on behalf of the company or by another person, or in a criminal charge of which he was acquitted, or a criminal charge in which he was
                  convicted of a criminal offense that does not require proof of criminal intent;</div>
              </div>
              &#160; <br>
            </td>
          </tr>
          <tr>
            <td style="width: 2.41%; vertical-align: middle;">&#160;</td>
            <td style="width: 2.28%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div>&#8226;</div>
            </td>
            <td style="width: 0.13%; vertical-align: middle;">&#160;</td>
            <td style="width: 95.17%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">a provision authorizing the company to indemnify an officer or director for future events with respect to reasonable litigation fees, including attorney&#8217;s fees, incurred by an officer or
                director due to an investigation or proceeding filed against him by an authority that is authorized to conduct such investigation or proceeding, and that resulted without filing an indictment against him and without imposing on him
                financial obligation in lieu of a criminal proceeding, or that resulted without filing an indictment against him but with imposing on him a financial obligation as an alternative to a criminal proceeding in respect of an offense that does
                not require the proof of criminal intent or in connection with a monetary sanction;</div>
              <div style="text-align: justify; line-height: 1.25;"> <br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 2.41%; vertical-align: middle;">&#160;</td>
            <td style="width: 2.28%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
              <div>&#8226;</div>
            </td>
            <td style="width: 0.13%; vertical-align: middle;">&#160;</td>
            <td style="width: 95.17%; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">
                <div style="line-height: 1.25;">a provision authorizing the company to indemnify an officer or director for future events with respect to a Party Harmed by the Breach;</div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: justify; line-height: 1.25;">&#160;
      <div style="line-height: 1.25;">
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 2.41%; vertical-align: middle;">&#160;</td>
              <td style="width: 2.28%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
                <div>&#8226;</div>
              </td>
              <td style="width: 0.13%; vertical-align: middle;">&#160;</td>
              <td rowspan="1" style="width: 50.28%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">
                  <div style="line-height: 1.25;">
                    <div style="line-height: 1.25;">a provision authorizing the company to indemnify an officer or director for future events with respect to expenses incurred by such officer or director in connection with an administrative proceeding,
                      including reasonable litigation expenses, including legal fees; and</div>
                  </div>
                </div>
                <div style="text-align: justify; line-height: 1.25;"> <br>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 2.41%; vertical-align: middle;">&#160;</td>
              <td style="width: 2.28%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
                <div>&#8226;</div>
              </td>
              <td style="width: 0.13%; vertical-align: middle;">&#160;</td>
              <td rowspan="1" style="width: 50.28%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">
                  <div style="line-height: 1.25;">
                    <div style="line-height: 1.25;">a provision authorizing the company to indemnify an officer or director retroactively.</div>
                  </div>
                </div>
              </td>
            </tr>
            <tr>
              <td style="width: 2.41%; vertical-align: middle;">&#160;</td>
              <td style="width: 2.28%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
                <div><br>
                </div>
              </td>
              <td style="width: 0.13%; vertical-align: middle;">&#160;</td>
              <td style="width: 95.17%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">
                  <div style="line-height: 1.25;"><br>
                  </div>
                </div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Limitations on Insurance, Exemption and Indemnification</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The Israeli Companies Law and our articles of association provide that a company may not exempt or indemnify a director or an officer nor enter into an insurance contract, which would provide
      coverage for any monetary liability incurred as a result of any of the following:</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z025c4f98726f4708a6a54429d13453b6" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 2.41%; vertical-align: middle;">&#160;</td>
          <td style="width: 2.28%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div>&#8226;</div>
          </td>
          <td style="width: 0.13%; vertical-align: middle;">&#160;</td>
          <td rowspan="1" style="width: 50.28%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">a breach by the officer or director of his duty of loyalty, except for insurance and indemnification where the officer or director acted in good faith and had a reasonable basis to believe
              that the act would not prejudice the company;</div>
            <div style="text-align: justify; line-height: 1.25;"> <br>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.41%; vertical-align: middle;">&#160;</td>
          <td style="width: 2.28%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div>&#8226;</div>
          </td>
          <td style="width: 0.13%; vertical-align: middle;">&#160;</td>
          <td rowspan="1" style="width: 50.28%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">a breach by the officer or director of his duty of care if the breach was done intentionally or recklessly, except if the breach was solely as a result of negligence;</div>
            <div style="text-align: justify; line-height: 1.25;"> <br>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.41%; vertical-align: middle;">&#160;</td>
          <td style="width: 2.28%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div>&#8226;</div>
          </td>
          <td style="width: 0.13%; vertical-align: middle;">&#160;</td>
          <td style="width: 95.17%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">any act or omission done with the intent to derive an illegal personal benefit; or</div>
            <div style="text-align: justify; line-height: 1.25;"> <br>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 2.41%; vertical-align: middle;">&#160;</td>
          <td style="width: 2.28%; vertical-align: top; font-family: 'Times New Roman',Times,serif;">
            <div>&#8226;</div>
          </td>
          <td style="width: 0.13%; vertical-align: middle;">&#160;</td>
          <td style="width: 95.17%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">any fine, civil fine, monetary sanctions, or forfeit imposed on the officer or director.</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; margin-left: 132.7pt; line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">5</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: justify; line-height: 1.25;">In addition, under the Israeli Companies Law, exemption of, indemnification of, and procurement of insurance coverage for, our directors and officers must be approved by our audit committee and board
      of directors and, in specified circumstances, by our shareholders.</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-style: italic; font-weight: bold;">Letters of Indemnification</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">We may provide a commitment to indemnify in advance any director or officer of ours in the course of such person&#8217;s position as our director or officer, all subject to the letter of indemnification,
      as approved by our shareholders from time to time and in accordance with our articles of association. We may provide retroactive indemnification to any officer to the extent allowed by the Israeli Companies Law. As approved by our shareholders on
      July 18, 2013, the amount of the advance indemnity is limited to the higher of 25% of our then shareholders&#8217; equity, per our most recent annual financial statements, or $5 million. In March 2021, our compensation committee and board of directors
      approved an amendment to the letters of indemnification with our directors and officers to provide for an increase in the limit on the amount of the advance indemnity to $10 million. This amendment is subject to approval of our shareholders.</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">As part of the indemnification letters, we exempted our directors and officers, in advance, to the extent permitted by law, from any liability for any damage incurred by them, either directly or
      indirectly, due to the breach of an officer&#8217;s or director&#8217;s duty of care&#160;<font style="font-style: italic;">vis-&#224;-vis</font>&#160;us, within his acts in his capacity as an officer or director. The letter provides that so long as not permitted by law, we do
      not exempt an officer or director in advance from his liability to us for a breach of the duty of care upon distribution, to the extent applicable to the officer or director, if any. The letter also exempts an officer or director from any liability
      for any damage incurred by him, either directly or indirectly, due to the breach of the officer or director&#8217;s duty of care&#160;<font style="font-style: italic;">vis-&#224;-vis</font>&#160;us, by his acts in his capacity as an officer or director prior to the
      letter of exemption and indemnification becoming effective.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">ITEM 7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;EXEMPTION FROM REGISTRATION CLAIMED</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">Not applicable.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">ITEM 8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;EXHIBITS.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">See Exhibit Index following the signature page.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">ITEM 9.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;UNDERTAKINGS</div>
    <div style="line-height: 1.25;"> <br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zad16a8eccb664a76ab8e40a6af4d8e8a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-bottom: 6pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="margin-left: 18pt; line-height: 1.25;">(a)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">The undersigned Registrant hereby undertakes:</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zf29e23333a7a4f459e050e1bd32aae9f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 12pt; margin-bottom: 12pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 54pt; vertical-align: top; align: right;">
              <div style="margin-left: 36pt; line-height: 1.25;">(1)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z57cd9a346b094ea7b452ed9a4d0fd672" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-bottom: 6pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 89.85pt; vertical-align: top; align: right;">
              <div style="margin-left: 72pt; line-height: 1.25;">(i)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; text-indent: 0.15pt; line-height: 1.25;">to include any prospectus required by Section 10(a)(3) of the Securities Act;</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z9bed1e6a3f244aee8de638e0194423ac" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-bottom: 6pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 89.85pt; vertical-align: top; align: right;">
              <div style="margin-left: 72pt; line-height: 1.25;">(ii)</div>
              <div style="line-height: 1.25">&#160;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; text-indent: 0.15pt; line-height: 1.25;">to reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof)
                which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement; and</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z1f91ca79bf5e44bf8430980cdd4e49e1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-bottom: 6pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 89.85pt; vertical-align: top; align: right;">
              <div style="margin-left: 72pt; line-height: 1.25;">(iii)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">to include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any
                material change to such information in the Registration Statement;</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: justify; margin-left: 53.85pt; line-height: 1.25;"><font style="font-style: italic;"> <br>
      </font></div>
    <div style="text-align: justify; margin-left: 53.85pt; line-height: 1.25;"><font style="font-style: italic;">provided, however,</font> that paragraphs (a)(1)(i) and (a)(1)(ii) above do not apply if the information required to be included in a
      post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Exchange Act that are incorporated by reference in the registration
      statement;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z1c4b584711174721b28bf2c13b8b8548" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-bottom: 6pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 53.85pt; vertical-align: top; align: right;">
              <div style="margin-left: 36pt; line-height: 1.25;">(2)</div>
              <div style="line-height: 1.25">&#160;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; text-indent: 0.15pt; line-height: 1.25;">That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement
                relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial <font style="font-style: italic;">bona fide</font> offering thereof.</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zda9c8198962b4381a8cb61fd0fca5fbb" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-bottom: 6pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 53.85pt; vertical-align: top; align: right;">
              <div style="margin-left: 36pt; line-height: 1.25;">(3)</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; text-indent: 0.15pt; line-height: 1.25;">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="z7317dcef650247c49050a81a3c5519f1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-bottom: 6pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="margin-left: 18pt; line-height: 1.25;">(b)</div>
              <div style="line-height: 1.25">&#160;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant&#8217;s annual report pursuant to Section
                13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall
                be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial <font style="font-style: italic;">bona fide</font> offering
                thereof.</div>
            </td>
          </tr>

      </table>
      <div> <br>
      </div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" id="zc5a7c49633a44f5f8262248cbf4e5ed2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 6pt; margin-bottom: 6pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top; align: right;">
              <div style="margin-left: 18pt; line-height: 1.25;">(c)</div>
              <div style="line-height: 1.25">&#160;</div>
            </td>
            <td style="width: auto; vertical-align: top;">
              <div style="text-align: justify; line-height: 1.25;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing
                provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In
                the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any
                action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling
                precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">6</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">SIGNATURES</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; line-height: 1.25;">Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on
      Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Tel Aviv, State of Israel, on this 25<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> day of March 2021.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="zb636e3cea8044cf981195ba055859fa1">

          <tr>
            <td style="width: 50.00%;">
              <div>&#160;</div>
            </td>
            <td style="width: 50%;">
              <div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">REDHILL BIOPHARMA LTD.</div>
                <div style="text-align: left; text-indent: 36pt; margin-left: 225pt; line-height: 1.25;"><br style="line-height: 1.25;">
                </div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><u>By: </u><font style="font-style: italic;"><u>/s/ Dror Ben-Asher</u></font></div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Dror Ben-Asher<br>
                  Chief Executive Officer&#160;and Chairman of the Board of Directors</div>
                <div style="line-height: 1.25;"><br style="line-height: 1.25;">
                </div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><u>By: </u><font style="font-style: italic;"><u>/s/Micha Ben Chorin</u></font></div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Micha Ben Chorin<br>
                  Chief Financial Officer</div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="text-align: center; line-height: 1.25;"><br>
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">POWER OF ATTORNEY<a name="POWEROFATTORNEY"><!--Anchor--></a></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; line-height: 1.25;">KNOW ALL MEN BY THESE PRESENTS, that each individual whose signature appears below constitutes and appoints Dror Ben-Asher and Micha Ben-Chorin his true and lawful attorney-in-fact
      and agent with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign this registration statement and any and all future amendments (including post-effective amendments) to the
      registration statement, and to file the same with all exhibits thereto, and all documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, and each of them, full power and authority
      to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and
      agent or any of them, or their or his substitute, may lawfully do or cause to be done by virtue hereof.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 27pt; line-height: 1.25;">Pursuant to the requirements of the Securities Act of 1933, as amended this registration statement has been signed by the following persons in the capacities and on the dates
      indicated:</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25"> </div>
    <div style="line-height: 1.25">
      <table cellspacing="0" cellpadding="0" border="0" id="z0512550a9a034bde8cc8e6b064023874" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25; font-weight: bold;"><u>Signatures</u></div>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25; font-weight: bold;"><u>Title</u></div>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25; font-weight: bold; text-align: center;"><u>Date</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top; text-align: center;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25; font-style: italic;"><u>/s/Dror Ben-Asher</u></div>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25;">Chief Executive Officer and <br>
              </div>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25; text-align: center;">March 25, 2021</div>
            </td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25;">Dror Ben-Asher</div>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25;">
                <div style="line-height: 1.25;">Chairman of the Board of</div>
              </div>
            </td>
            <td style="width: 33%; vertical-align: top; text-align: center;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25;">Directors</div>
            </td>
            <td style="width: 33%; vertical-align: top; text-align: center;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top; text-align: center;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25; font-style: italic;"><u>/s/Micha Ben Chorin</u></div>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25;">Chief Financial Officer</div>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25; text-align: center;">March 25, 2021</div>
            </td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25;">Micha Ben Chorin</div>
            </td>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top; text-align: center;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top; text-align: center;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25; font-style: italic;"><u>/s/Eric Swenden</u></div>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25;">Director</div>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25; text-align: center;">March 25, 2021</div>
            </td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25;">Eric Swenden</div>
            </td>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top; text-align: center;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top; text-align: center;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25; font-style: italic;"><u>/s/Dr. Kenneth Reed</u></div>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25;">Director</div>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25; text-align: center;">March 25, 2021</div>
            </td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25;">Dr. Kenneth Reed</div>
            </td>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top; text-align: center;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top; text-align: center;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25; font-style: italic;"><u>/s/Ofer Tsimchi</u></div>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25;">Director</div>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25; text-align: center;">March 25, 2021</div>
            </td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25;">Ofer Tsimchi</div>
            </td>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top; text-align: center;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top; text-align: center;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25; font-style: italic;"><u>/s/Rich D. Scruggs</u></div>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25;">Director and Chief Commercial Officer</div>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25; text-align: center;">March 25, 2021</div>
            </td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25;">Rick D. Scruggs</div>
            </td>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top; text-align: center;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top; text-align: center;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25; font-style: italic;"><u>/s Alla Felder</u></div>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25;">Director</div>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25; text-align: center;">March 25, 2021</div>
            </td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25;">Alla Felder</div>
            </td>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top; text-align: center;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top; text-align: center;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25; font-style: italic;"><u>/s/ Shmuel Cabilly</u></div>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25;">Director</div>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25; text-align: center;">March 25, 2021</div>
            </td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25;">Shmuel Cabilly PhD</div>
            </td>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top; text-align: center;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top; text-align: center;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25; font-style: italic;"><u>/s/Alessandro Della Ch&#224;</u></div>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25;">Director</div>
            </td>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25; text-align: center;">March 25, 2021</div>
            </td>
          </tr>
          <tr>
            <td style="width: 33%; vertical-align: top;">
              <div style="line-height: 1.25;">Alessandro Della Ch&#224;</div>
            </td>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
            <td style="width: 33%; vertical-align: top;">&#160;</td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="line-height: 1.25">
      <div style="line-height: 1.25">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 50.00%;">
                <div>&#160;</div>
              </td>
              <td style="width: 50%;">
                <div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">REDHILL BIOPHARMA INC.</div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Authorized U.S. Representative</div>
                  <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><br>
                    By&#160; <font style="font-style: italic;"><u>/s/Micha </u><u>Ben Chorin</u></font><br>
                    Name:&#160; Micha Ben Chorin<br>
                    Title:&#160; March 25, 2021</div>
                </div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: center; line-height: 1.25;"></div>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div id="DSPFPageNumberArea" style="text-align: center;"><font id="DSPFPageNumber" style="color: #000000; font-weight: normal; font-style: normal;">7</font></div>
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">
      <div style="text-align: center; line-height: 1.25;">EXHIBIT INDEX</div>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <table cellspacing="0" cellpadding="0" id="ze33af06026e94f92a1963e5bbe76f848" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 19.78%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Exhibit</u><br>
              <u>Number</u></div>
          </td>
          <td style="width: 80.22%; vertical-align: bottom;">
            <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>Description</u></div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.78%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;"><a href="https://www.sec.gov/Archives/edgar/data/1553846/000155837021003168/rdhl-20201231ex11df69137.htm">4.1</a></div>
          </td>
          <td style="width: 80.22%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;"><a href="https://www.sec.gov/Archives/edgar/data/1553846/000155837021003168/rdhl-20201231ex11df69137.htm">Articles of Association of the Company, as amended (unofficial English translation)
                (incorporated by reference as Exhibit 1.1 to Annual Report on Form 20-F disseminated with the Securities and Exchange Commission on March 18, 2021).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.78%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;"><a href="#POWEROFATTORNEY">4.2</a></div>
          </td>
          <td style="width: 80.22%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;"><a href="#POWEROFATTORNEY">Form of Deposit Agreement among the Registrant, the Bank of New York Mellon, as Depositary, and all Owners and Holders from time to time of American Depositary
                Shares issued hereunder (incorporated by reference as Exhibit 1 to the Registration Statement on Form F-6 filed by The Bank of New York Mellon with the Securities and Exchange Commission on December 6, 2012).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.78%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;"><a href="https://www.sec.gov/Archives/edgar/data/1553846/000155837020001994/rdhl-20191231ex410c8e164.htm">4.3</a></div>
          </td>
          <td style="width: 80.22%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;"><a href="https://www.sec.gov/Archives/edgar/data/1553846/000155837020001994/rdhl-20191231ex410c8e164.htm">RedHill Biopharma Ltd. Amended and Restated Award Plan (2010). (incorporated by
                reference as Exhibit 4.10 to Annual Report on Form 20-F disseminated with the Securities and Exchange Commission on March 4, 2020).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.78%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_5-1.htm">5.1*</a></div>
          </td>
          <td style="width: 80.22%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_5-1.htm">Opinion of Gross&#160;&amp; Co.</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.78%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_5-1.htm">23.1*</a></div>
          </td>
          <td style="width: 80.22%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_5-1.htm">Consent of Gross&#160;&amp; Co. (included in Exhibit 5.1).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.78%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_23-2.htm">23.2*</a></div>
          </td>
          <td style="width: 80.22%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;"><a href="exhibit_23-2.htm">Consent of Kesselman &amp; Kesselman.</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.78%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;"><a href="#POWEROFATTORNEY">24.1*</a></div>
          </td>
          <td style="width: 80.22%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;"><a href="#POWEROFATTORNEY">Power of Attorney (included on signature page).</a></div>
            <div style="text-align: justify; line-height: 1.25;"> <br>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 19.78%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">* Filed herewith.</div>
          </td>
          <td style="width: 80.22%; vertical-align: top;">&#160;</td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; text-align: center;">8<br>
    </div>
    <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>exhibit_5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using EDGARfilings PROfile 7.4.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div id="DSPFPageHeader">
      <div style="text-align: right; line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><u><font style="font-weight: bold;">Exhibit</font>&#160;<font style="font-weight: bold;">5.1</font></u></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-weight: bold;"> <br>
        </font></div>
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-weight: bold;"> <img src="capture.jpg"></font></div>
    </div>
    <div style="text-align: right; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: right; line-height: 1.25;">Tel-Aviv, March 25, 2021</div>
    <div style="line-height: 1.25;">RedHill Biopharma Ltd.<br>
      21 Ha'arba'a St.</div>
    <div style="line-height: 1.25;">Tel Aviv 6473921</div>
    <div style="line-height: 1.25;"><u>Israel</u></div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">Re:&#160;<u>Registration on Form S-8</u></div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25;">Ladies and Gentlemen:</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">We have acted as the Israeli counsel to RedHill Biopharma Ltd., a company organized under the laws of the State of Israel (the &#8220;<u>Company</u>&#8221;), in connection with its filing of a registration
      statement on Form S-8 on March 25, 2021 (the &#8220;<u>Registration Statement</u>&#8221;), under the Securities Act of 1933, as amended, relating to the registration of 16,526,070 of the Company&#8217;s ordinary shares, par value NIS 0.01 per share (the &#8220;<u>Plan
        Shares</u>&#8221;), reserved for future issuance under the Company&#8217;s Amended and Restated Award Plan (2010) (the &#8220;<u>Plan</u>&#8221;).</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">In our capacity as counsel to the Company, we have examined originals or copies, satisfactory to us, of the Company&#8217;s (i) Articles of Association of the Company, as amended, (ii) the&#160; Plan, and (iii)
      resolutions of the Company&#8217;s board of directors. In such examination, we have assumed the genuineness of all signatures, the legal capacity of natural persons, the authenticity of all documents submitted to us as originals and the conformity with the
      original documents of all documents submitted to us as copies or facsimiles. As to any facts material to such opinion, to the extent that we did not independently establish relevant facts, we have relied on certificates of public officials and
      certificates of officers or other representatives of the Company. We are admitted to practice law in the State of Israel and the opinion expressed herein is expressly limited to the laws of the State of Israel.</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">On the basis of the foregoing, we are of the opinion that the 16,526,070 Plan Shares being registered pursuant to the Registration Statement, when issued and paid for in accordance with the Plan,
      pursuant to agreements with respect to the Plan, and, as the case may be, pursuant to the terms of the awards that may be granted under the Plan, will be validly issued, fully paid and non-assessable.</div>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">We hereby consent to the filing of this opinion as an exhibit to the Registration Statement.</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">&#160;&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="za052a3b8da554ec4b7fb45dcef06d5ed">

        <tr>
          <td style="width: 50%; vertical-align: bottom;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 50%; vertical-align: bottom;">
            <div style="line-height: 1.25;">Very truly yours,</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            <div style="line-height: 1.25; font-style: italic;">/s/&#160;Gross &amp; Co.</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>exhibit_23-2.htm
<DESCRIPTION>EXHIBIT 23.2
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using EDGARfilings PROfile 7.4.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><u><font style="font-weight: bold;">Exhibit 23.2</font></u><br>
    </div>
    <div style="line-height: 1.25;"><img width="67" height="67" src="image00002.jpg"></div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25;">We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated March 17, 2021, relating
      to the financial statements and the effectiveness of internal control over financial reporting, which appears in RedHill Biopharma Ltd.'s Annual Report on Form 20-F for the year ended December 31, 2020.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="z8cfb3b11ce8948ae9bb0af8bfe98f9c7">

          <tr>
            <td style="width: 50%; text-align: left; vertical-align: middle;">
              <div><font style="font-family: 'Times New Roman',Times,serif;">Tel-Aviv, Israel</font></div>
              <div><font style="font-family: 'Times New Roman',Times,serif;">March 25, 2021</font><font style="font-family: 'Times New Roman',Times,serif;"> </font></div>
            </td>
            <td style="width: 50%;">
              <div>
                <div style="text-align: left; line-height: 1.25;">/s/&#160; Kesselman &amp; Kesselman</div>
                <div style="text-align: left; line-height: 1.25;"><font style="font-family: 'Times New Roman',Times,serif;">Certified Public Accountants (Isr.)</font></div>
                <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">A member firm of PricewaterhouseCoopers International Limited</div>
              </div>
            </td>
          </tr>

      </table>
    </div>
    <div style="line-height: 1.25;"> <br>
    </div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="3" border="0" id="z5d4666c9cbaf450a992b7517b9cb7a3a" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="border-left: 1px dotted #000000; border-top: 1px dotted #000000; vertical-align: top; width: 100%;">
              <div style="margin-left: 1pt; line-height: 1.25; font-style: italic;">Kesselman &amp; Kesselman, Derech Menachem Begin 146 Tel Aviv-Yafo 6492103 Israel,</div>
              <div style="margin-left: 2.65pt; line-height: 1.25; font-style: italic;">P.O Box 7187 Tel-Aviv 6107120 Telephone: +972 -3- 7954555, Fax:+972 -3- 7954556,
                www.pwc.com/il</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>capture.jpg
<TEXT>
begin 644 capture.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#N17AI9@  34T *@    @ ! $[  (
M   ,   (2H=I  0    !   (5IR=  $    8   0SNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $1A=FED($5L
M<V]N   %D ,  @   !0  !"DD 0  @   !0  !"XDI$  @    ,T,   DI(
M @    ,T,   ZAP !P  " P   B8     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*BHJ*BHJ*O_  !$( $, V0,!(@ "$0$#$0'_Q  ?   !!0$! 0$! 0
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H !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image00002.jpg
<TEXT>
begin 644 image00002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0G!V(# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH ***2@!:2BB@04E+24Q,2BEHH$%+110-!1112&
M%)2TE,3$I:*6@04444%(6BBBD,**** "BBB@ HI**5P%HI**5P"BBBIN,***
M*+@%%%%', 44447 ****=P%HI**=Q"T4E&:=P%HHHIW 2BBB@3$HHI*9+"BB
MBBX@HHI:+C"BBBI;&A:***AE(*2EHJ6,2BBEH ****I +1245=Q"T4447 **
M*3-,!:*2B@!:*2B@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH ***2@ HHI*9+"DHS102V)11
M24R6%%%%,04444 2T445!N%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "4444Q,2BBB@D
M*6DI:!A112TAV$I:**!A1110 E%+10 E%+10%A*6BB@ HHI*+@+129HS2N.P
M44F:3-9N0"T4E%9N0"T4E)2YAV'44VC-',%A:*3-%2Y +1244N8!:6FT9IJ0
M6'44W-&:KF"PZBFTM',%A:6FT52D(=124M6I %)115<Q+$HHHIW)L%%%+1<=
M@HHI:5QV"DI:2I;'86BDHI7&+124N:$T 4444[H HI**5P%HI**+@+1115)@
M%%%%4B6)1115(04M)2TP"EI*6D4%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E+24"8E)2TE,AB4E+
M24R0HHHQ3$%%+10 E%+10!)1114&X4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)2T4
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M6)**9NI<U:8K#J6FYI<U2$+1115( HHHJD(***6JN*PE%+13&%%%% !1110
M44F:* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH 2BEHH%8;BDQ3Z2G<5AN*,4ZDH%82C%+10*PF**6B@+#J
M***1H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!A24M)0 4M)10*XM%)2T%(6BBBD,**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2BEHH&-Q28IV**
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 E%%(
M:8F%)FBDID-A124M!-PHHI:!V$HI:* L%+24M(84M)2T%(!2TE+2*"DHHJ6P
M"BBDK-L84AI:0]*AC(VJ!S4SU6D-8R-8$$C52E:K$IJC,U8R.N"*=R_6L6Z;
MK6G<MUK&NFZUBSIBC)NCUK'G/-:=R>M94YYK-LVBB GF@-3":3-8R-HHG#4\
M/58-3MU821O%%C?1NJ#=2YK)HVBB;=1NJ+-&:R9JB7=2[ZAS2;JFQHBQOI-]
M0;J-U*QHB;?2%JBS1FE8I$FZEW5'FDS189,&I=]09HW46)9/OI"]0;J-U.PB
M4M3=U1YHS3 DW4NZHLT9JD(FWT[?5?=1NIV(98WT;Z@W4H-%B63;J3=4>:":
M1(\M32]1DU&6IV'8G\RE$E5-]*'JK#L7ED]ZF62J"O4RM2: O+)5A)*SU:IT
M:I)9HI)5E):S$>IU>E<QD::R^]3++6:KU*LE*YDS266I%EK/62I%>E<S:-!9
M?>I1+[UG"2GB2BYFT:2S>]2+-68):D$M',9N)IB;WJ035F++4JR4^8QE$T1+
M3Q+5 24\/5J1DT7A+2^=[U1\RCS*M3,VC0\_WH\_WK.\VCS:M3):-#S_ 'I/
M.JAYM'FU:D9N)=,WO33-[U3\SWIIDK12(<2X9J89JIF6F&6M8R#E- 3>]2I+
M66):GCDK53%RFJDE6$:LZ)ZMQM6BF2XEU34RFJR&IE-:QD38L*:D!J!34JFM
MXL5B4&G5&#3A6J%8?2TVG5JB0HHHJA"T4E%%P%HI*6G< HHHI@%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 )12TE FAN*,4ZC%.Y+B,I:7%&*!<HE+124
M +1110,**6B@=@HHI:0[!1110,2BEI*EH I*6DJ&AA332TAK-H:(WZ55DJR_
M2JTE92-8%*6J$U:$M4)JPD=D#+N>]8UT>M;-S6)=]ZQ9TQ,:Y/6LF=N:TKH\
MFLF<\UDS:)$30*9GFI$K*1O$<!3PM.45*%K&1T11#MI=M2[:0K63-4B/%&*?
MBDQ6;1JD-Q2;:DQ2[:AFB1%MHVU-MHVTKFB1#MHQ4N*;BE<I(9BC%/Q1B@=A
MF*-M28IVVBY+1#MHVU-MHVT[DV(=M&VI=M)MH$18HVU+MI=M4A$.TT;:FVT;
M:T0K$.VEQ4NVC%%B;$>*"*?BDQ4V%8B(J,K5@BF[: L5]E 2I]M."4<PR)5J
M95IP6I M2V2P45.@IJK4Z+4MDL<BU.JTU%JPBU#9DT"K4JBE5:D"U+D0T(!4
M@I *>!2YB&APIXIH%2**ER,VA0*>!0HJ0"IYS)H%%2K2 5(!1SF30X4\4T"G
M@52J&30M)BG@4H%6ID.)'BC%2[:-M6IDM$.*2I2*:16BF0T1TTU(13#6JF18
MC-,-2&F5K&86 =:L1U .M6$K6,A6+<1J[&:I15<CK>+%REQ#4ZU62K"5O AQ
M)UJ5:B2IEKIB9,<!3P*0"G5LB& I:2EK1,D6BBBJ ***6JL(2EHHIV ****8
M!1110 444E "TE%%,5PHI**!7%HI** N.HHHI%!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)F
MBB@ HI,TF:=AV'44W-+FBP6%S2TE%(0M%%% !1110 4E+24@"BBBI&%%%%2
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHI* "BBBF%PHHHH%<*6DHI!<6BDHH"XM)110%PI*
M**8@HHI*!"T44M2QH****DI!2&EI#4M#(GZ53EJW)TJE,:SDC2!1F/6LVX-7
MYVZUEW#=:PDCJ@C,NSP:YZ]/6MN[?K7/WK=:Q:.J*,"]/6L.Y/-;%XW6L.Y/
M-2T;Q*Y;FE5JB+<T!JFQTP+:M3P]5 ]/WTK'5 L[Z0O4&^C=4-&R)B])OJ'=
M2;JAQ-4B;?1OJ'=2;J7*:Q1/OHWU!NI-U3RFJ18W^]&^H-U&ZCE'8GWTN^J^
MZEW4<H6+.^EWU6W4N^ERD\I9WT;ZK;Z7?2Y1<I8WT>95?=2[J.4.4L;Z<)*K
M;J7=2Y2'$M"2G>957?2[ZGE,G$L^92^95;=2[J5B>0L>8:3S#4.:,T6'R$OF
M&D\RHB:;NIV*42;S*7S*K[J-U/E+2+0DIPDJJ&IP:I<1V+8D-/$IJH&IX:H<
M1\I<$M2"6J(>GB2H<0L7Q-4@F]ZSQ)3Q)4. 6- 34\3'UJ@)*D#UFXDV+XF]
MZD$U9X>GB2H<0Y30$U/$U9XDIPD]ZAP%RFAY_O1Y_O5'S*/,I<@N0N^?1YYJ
MGOHWT<H<I=\\TOG^]4=]'F4<I#B7O/\ >@S^]4?,H\RGRD.)<,Y]::9SZU4\
MRF[ZI1)Y2Y]H/K1]H/K5+?2>96JB)Q+_ -H/K2_:/>L[S*3SJUC$S<34%S[T
MOVCWK*\[WIXFK6,3-Q-07!]:>+@UF++4JR5O%$.)J)<'UJU'<&L='JU')6T4
M9N)M1W!]:MI<>]8L<M64E]ZWBC&2-87'O1]H]ZS1-[TOFULD92B:'VCWI1<'
M/6LWS:<LE:)&+@:\<_O5N.?WK%CEJW'+6J1FX&U'+5I)*QHY:N1RUHC)P-9'
MJPC5FQR5;C>M$92B7E-2 U71JF!JC)HDHI!2T$"XHQ12TA"8I:** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****5P"B
MBBF 4444 %%%% !24M)0(*2EI*9+"BDHH$+1249H"XM%)10%Q:*2B@84M)24
M"%HI*,T@N.I:;2TF4A:***DH*0TM(:!D,G2J$]:$G2J$W>HD:0,RX/6LFY/6
MM:<=:RKD=:YY'7!F)=GK7/WK=:Z"\'!KG;[O631U19S]XW6L2X;FM>]/)K"N
M6YJ;&\2%FYI :C+<TJFE8Z($H-/!--44\+4LZ8!DT9IVVDQ4LZ8B9HS125#.
MB*%S3<TM&*1JD)FC-+BC;2-%$3-+FEVTNVD5RB9I,T[;1MI%<@F:,TNVEVT!
MR#<FES2[:7;0'((#2YHQ2XI6$Z89IV: *4"E8ATQ,FG4H6G;:+&;IC>:>*-M
M+BI:)]F I:,45-@Y!IIIJ3%)MII!R$5 S4FREV50N48*D%*$IP6I920@IU*%
MIP6H95AM.&:>$IPCJ6R;#!FGJ33Q'3A'4-H+"*34@- 2G!:AARC@33@32!:>
M%J+#Y0!-.!-*%IP2E8+#<T[)I=E+MJ6A6$R:,T[;1MI"Y1N31FG;:-M"1+B,
MR:3)I^VC;5*(N09DT9-/VTFVK427 9FFDFI=M)LK1(AP("33234YCI/*K5(A
MQ(,FGJ34GE4X15K%&;B"DU.I--6.I56M8HS<21#5A#4*+5A%K6*,91)T8U.K
M&H46K"K6T48RB/#&EW&C;1MK9(R<0W&G*U-Q3E%:)$.)81C5J-JJ1BK<:UHD
M9M%R-C5R)C5.):NQ+5I&4D7(F-7HC5*):NQ"M$CGF78S5A:K1U86J.>1(*=3
M!3Z#-BTM)14DBTF:*3- ["YHIN:,T[!8=13<T46"P^BBBD(**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,=3+3.>0\4X4VEI$#Z*;FC-(FP&DI:2F,2BEQ1B@8E%+BB@"2BBBI("BBB@
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MM+BDS1F@0N**3-% #J***0@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ5109MBJM2 4@%/ H,VP%.I*6@D*6DI:0@HHHH **** "BBB@ HHHH ****
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M\D>E+Y(]*7*2ZAS_ /9H_NT?V:/[M=#Y(]*3R1Z46%[1G/?V</2D_L\?W:Z
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M44 +12452 6BDS2TP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %)2TAI6 *;FEIAI@+FDW4TTE $F:7-1BGB@!]
M%)2BE8!:***8!1110 44F:,TK +129HS18!:*,T4P$I,4ZC% $>*3%28HQ0!
M'BG 4[%&* $Q2TM% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4AI:* (F6HF2K.*;MH J&.F^55S91L% %41U(
M$J;92[: (PM. I^*7% #<4ZC%+0 E+110 4444 %%%% !1110 4444 %%%%
M!129HS0 M%-W4;A0 ZBF[J7- "T49HH **** "BBB@ HHI,T +129HS0 M%)
MFC- "T4F:6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MNIE)F@"3=1NJ/-+F@"3=2YJ,4X4 /S2TT4Z@!:*** "BBDS0 M%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 44F:,T +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !112&@ --)I34;4 !:F[Z833": )M
M].#57!-/4T 6 :=42U(* '4444 %%%% !1129H 6DHS3<T +FDS32:;F@!VZ
MC-,S2T +1B@4[% #,4E2$4PT -S1OIK5&2: )P].#U6!-2*: )P:>*A6I!0
M^BDI: "BBB@ HHHH *2EI* $S2$T&F&@!VZC=3*!0!)FG9J,4X4 .I:2EH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI,T
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M*3-)NH =13=U&X4 .HIF\>M&\4 /HIF\>M+N% #J*;NI<T +129HS0 M%%%
M!1110 4444 %%)FC- "T4W=1N% #J*9O%&\>M "FF$4N\>M-WCUH 85II6I-
MPI,B@!@6G!:<,4X8H  *>*04Z@!:*** "D-!I#0 A--+4AJ)C0 \O2;ZB)I
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M+?+_ 'J --KG'>HS=^]8DFH+_>JLVHC^]0!T1O!ZTGVWWKFCJ0_O4PZD/[U
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*0TW>*:9!ZT .+5&7J-Y@.]5I+@#O0!9:7WJ-KC'>L^2[ [U5DO1ZT :K76.
M]1-> =ZQ)+\?WJIR:B/[U '1-?@=ZB;40/XJY>34Q_>JK)JO^U0!US:F!_%4
M;:J!_%7&/JW^U5635_\ :H [9]7 _BJC/K(_O5QDNL_[59MQK77YJ .QN-;
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M,ZEJ((;YJIWFJ8S\U<W?:EG/S4 1ZK?9W<UQ>I762>:T-0O=V>:YB]N,YYH
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M\?+6O;Z9T^6MVVTP<?+6O;Z8./EH P(-+_V:OII7'W:Z:#3!Q\M:$>F#'W:
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MIK N^];][U-<_=]Z ,2Z[UC7/>MBZ[UC7'>@#/DZU$:DDZU$: %%.6F"I4%
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MU=G+\HYKA-,FZ<UU=E-\HYH Z2)\U:3!K*@EZ<U?B>@"V$!H:(8Z4J&IL9%
M%%X!Z55EMQZ5K%,U$\5 '.7%M[5SVH6_7BNVGAX/%<YJ4/!H \]U2'&[BN-U
M),;J[_5H\;JX75!RU '(W@^8UF2=:U+W[QK+DZT 0$5&14V*;MH @(I,5.5I
MA6@"+'-31]:9CFI8^M &M9=JZG31R*Y>Q'2NJTT<B@#K-.'2NJL1P*YC3EX%
M=78KP* -JU' K8MQTK+MEX%:UN* -&&KBG JG%4Y; H D:3%027&.]0338[U
MF7%WC/- %R>[ !YK U"\&#S45U?XSS7/W]_UYH IZI=_>YKB=4N>6YK7U&\S
MNYKD=0N,D\T 9%_.2QYK'EE.>M6;R3)-9LC<T #.349-&:2@!A%)BI,4W% #
M**<13<4 )1110 HJ>+K4 J:/K0!KVAZ5T5B>17-VAZ5OV3<B@#J[%NE=)9-T
MKD[)^E='92=* .JLVZ5OV9Z5S%D_2NBLFZ4 =#;'I6G'TK*M3TK4CZ4 3"@T
M"@T 0R=*R+P<&M>3I65=]#0!S-^.M<M?KUKK+\=:YB^7K0!REZO6L"[7K737
MJ]:YZ\7K0!SMV.M8MP.M;MV.M8ER.30!F..:B(J=QS4>V@!H%3QIS352K<,?
M(H NV<62*Z6PM<XXK*T^#)'%=AI=KDCB@"]8V.<<5T-KI_ XJ33;'('%=+;6
M'R=* ,9+3:.E2A=E;$EKM'2LVY&R@"!IMHZU2N;OY>M1W,^W/-8EW><'F@!M
M_=Y!YKE=0N,YYJ[>7><\USUY/G/- &;>R9)K(D:KES)G-9[&@",TF*>!3@M
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MA3@:8*<* )5-6(FJJ#4T9YH V;-OF%=1IS?=KDK-OF%=1IS?=H [733TKK;
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M!S\M 'DT^DG^[6=-I3?W37J\^AC^[69-H?\ LT >72:6WH:@.EMZ5Z3)H?\
MLU#_ &'_ +- 'G?]E-Z4]=);^Z:]#&A?[-2KH(_N4 >?Q:2V?NUJVVE-Q\M=
MG'H0S]VM&#1 ,?+0!R]II9X^6MZTTT\?+6_;:.!CY:UK?2\8^6@#(M+#&.*W
M[2SQCBKD&GXQQ6G!9X[4 ):08QQ6U;)BH(8,=JOQ)B@"=!4E, I] !24M% #
M33#4E)B@"*BI,4F* &BG"EQ2XH *444M !1110 4444 %%%% !1110 4444
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M,D<4 1V6GYQQ7166F=/EJ[I^F9Q\M=18Z5T^6@#+L]-QCY:Z&RLMN.*T;?3
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M%&*6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MTW6@#'N>]9%Q6K<GK63<'K0!0DZFHN]22=:A)H >#3LU'FES0 _-(33<TF:
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M6R'S"NMTL<K0!V6ECA:[+3@<"N3TI.%KL].CZ4 ;=L#@5IPCI5.VCX%:424
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MIFG_ '>*Z_3].''%,T_3L8XKJ+&SQCB@!+6P  XK7@LP.U3P6V .*OQPX[4
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MH [O21PM=KIH'%<3I)X6NUTUNE '1VX&*T(Q6=;MP*T(S0!:2IUZ5 AJ=>E
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M!N^]=#>+UK NQUH Q+CJ:I.:NW'>J+T ,S1FDHH 7-%)2T %2Q]:CQ4T8YH
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MV;(XKN='@(V\5FZ?IF,?+77Z99;<<4 ;^E1D!:ZZS7Y!6#IT&T#BNDM5PHH
MNH.*DQ34'%/H 2FM3C3&H B:J[U.YJM(U %*X'%<[J/1JZ"X;@USVHGK0!QF
MK=&KA]3ZM7<ZKT:N*U)>30!Q]Z/F-94@YK;O8_F-94D?- %$@TPBK31U&4H
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M;@N^G-7X[OWH Z!)!ZU.LH]:P4O..M2_;>.M &WYR^M(;A1WK ?4 .]5I-5
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M;'2 <?+6_:Z2HQ\M6[*TP!Q6S#;X XH I6^GA>U:<%N%[5.D6.U3HF* %C3
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M!AOQQ\U7$U ?WJX%-6Q_%4PUD#^*@#OUU(?WJ4ZF,?>K@/[< _CIC:Z,??H
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M"@!12BC%+0 M+24M !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0!B$L?6HRC'L:Z5=()_AJ9-$)_AH Y+R6/8T];9CV-=DF@D_P58C\/G^Y^E
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M6UM2<<5N6=F<CBM&VTD\?+6Y9Z61CY: *5G8].*Z"SL.G%7+/3<8^6MVUL,
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &M
MTJI/]TU;;I52?[IH P[T\&N8U!NM=-?=#7,:@.M ',7[=:YR\?K717XZUS=X
M.M &%=MUK#NFZUMW8ZUAW7>@#)G-4V-6KBJ;4 )NI=U1T4 2[Z-U1THH =FG
M+2 5*BT 3P)DUL6L.<<51M8\FNAL;?)'% %JTM,XXK9M[#(Z5+86><<5TEG8
M9 XH PQIN?X:0Z9_LUV,>FY'W:D_LO\ V: .%;2O]FHSI/\ LUWO]D_[-)_9
M'^S0!P7]D_[-+_9'^S^E=Y_8_P#LT[^R/]F@#@QI'^S4T>C\_=KN!I'^S4R:
M3S]V@#CHM%S_  U?AT,'^"NMBTO'\-7X=. _AH Y*+01_<_2KD>@#^Y^E=='
M8@=JM)9CTH X]-!']RK":&/[GZ5UJV@]*D%J/2@#EDT0?W:M1Z.!_#72+;#T
MJ58!Z4 8$>D@?PU;CTP#^&ME81Z5,L8H RDT\#M5A+(#M6B$%.VB@"DMMCM4
MRQ8JQBC% $82G;:?10 W%+2T4 %%)29H =13,T;J '44W-+F@!:3%+2T ,VT
MTIQ4M(: *DD>:RKNWSGBMQA5.>+.: ..OK+=GBN:O=-SGY:]"N+7.>*R;BPS
MGB@#S>XTG+?=JFVC_P"S7H<NF9/W:@.E?[- ' ?V/_LTHT?_ &:[S^R?]FE&
MD_[- '"#1_\ 9J5='_V:[<:5_LU(NE_[- '%)H_^S^E68]'_ -FNQ73/]FIT
MTW_9H Y>#2<8^6M:VTO&/EK<BL,8XJ[%9X[4 9UMI^,<5J060 Z5<BM\=JN1
MQ8[4 58[7':K:0X[5.J5(%H 8J8J4"@"EH 2FDTXTTB@!N:,TN*3% #@:6D
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 UJJS_=-6FJK/\ =H PKT<&N:OQUKI[P<&N;OQUH Y6^7K7-WB]
M:ZB^7K7.WB]: .:NUZUA70ZUT5XO6L&['6@##N.M47K0N1S5%Q0!#13L4E !
M3Q3:<* ) *L1+58&K,3<T :MDF6%=5IL()%<M8O\PKK=,<96@#KM,M@=O%=;
M868('%<UI3CY:['3G&!0!H0V (Z5973QZ5/;L,5?C(H S1IH_NT\:6/[M;"
M5,J"@#"_LL?W:7^RQ_=K?$8I?+'I0!@?V6/[M.&FC^[6[Y8]*-@H QET\#M4
MRV8':M/8*7:* *"VV.U2"#VJYM%&* *OD^U.$56,48H @$=."5+BC% # M.
MIU% "4M%% !1110 4444 %)2TE "&FDTXTTB@!N:3-+BDQ0 N:<#3<4X"@!U
M+24M "T4E)F@ -1LF:?FC- %1X,]JKO9@]JTZ-HH QFT\'M3#IP]*W-@HV"@
M##_LT?W:/[-']VMS8*-@H Q/[.'I2C3Q_=K:V"C8* ,<6 ]*<+$>E:^P4;10
M!F+9@=JE6VQVJ]M%)@4 0+#BI F*?1F@  I<4F:7- "T444 %)BEI,T )BC%
M&:,T +BEI,TM "$5&R9J6B@"HT&>U0-:@]JT*3 H RVL@>U1'3P>U;&!1M%
M&(=-']VF'2Q_=K?V"C8* .?_ ++']VC^RQ_=KH?+%'EB@#G_ .RQ_=I1I@_N
MUO\ EBCRQZ4 88TX#^&I5L .U:^P4NP4 9BV8':I%ML=JO[12[: *BP8[5*L
M>*FQ1B@!H6G"EHH **** "DI:2@ I,4N:3- "8I<4F:,T .Q129I: %HHHH
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MA30*=0 M+249H 6BFYHS0 ZBFYI<T +129I: "BBB@ HHHH **** $-%!I*
M&DTTFG$4TB@!,TN:3%+B@!P-.%- IU "TM)1F@!:*;FC- #J*;FC- #J*3-+
M0 4444 %%%% "4F*=10 S%&*?10 W%+2T4 %%%% !1110 4444 %%%% !24M
M)0 48I,T9H 7%%)FC- "TM)2T %%%% !1110 4444 (:*#24 (332:<:810
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MI@%.% #Z6FTHH 6BBB@ HHHH **** "BBB@ HHHH 2FDTZFF@!I-)F@BDQ0
MN:<#3 *<!0 \4M-%.H 6BBB@ HHHH 3%)BG44 ,VT8I])0 F*6BDS0 M+3<T
M9H =13<T9H =13<TN: %HI,T4 %)BEHH ;BC%+FDS0 8I<49I: "BBEH 2DQ
M3J* &8HVT^B@!N*7%+10 E%+10 W%)BGT4 ,VT8I]% #<4M+10 E-)I3330
MA-)FD--H ?FG U&*<* )!2TT4Z@!:*2C- "T4W-&: '44W-&: '4E)FC- !B
MDQ3LT4 -VT8IU% "8I:,TF: %II-&::30 $TF:*3% "YI0::*<!0 X4ZFBG4
M +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "4TFG4TT -)
MI,T$4F* %S3@:8!3@* 'BEIHIU "T444 %%%% !129I,T .I*3-&: #%)BES
M2T -Q2;:?10 S;1MIU% "8I<4F:7- "XHHHH 6BDHS0 M%-S1F@!U%-S2YH
M6BDI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4TM !FC-)10 [-.%,%.% #J6DI: "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ I*6B@!N*3%/HH CQ1MI^*,4 ,VT;:?BC% #,4N
M*=BEH ;BEI:* $I,4ZB@!F*3%24F* &XI<4N*6@!*6BB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH 2DQ3J* &8HQ3Z3% #<4N*=10 E%+10 E)BG44
M ,Q2;:?BC% #-M&VGXHQ0 S;2XIV*,4 -Q3J6B@!**6B@!F*,4^DQ0 S%+BG
M8I: &XI:6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *2EHH ;BDQ3Z* (\48I^*,4
M -Q3L4M% "44M% #,48I])B@!F*7%.Q2T -Q2TM% "4F*=10 S%)BI*3% #<
M4N*7%+0 E+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH 2FXI])B@!FVDVU)BC% #-M+BG8HQ0 8HQ2T4 %%%% !1110 4444 %%%%
M !129HS0 M%)FC- "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 444F: %HI,T9H 6BDS2T %%%% !1110 4E%(: $S29I#3: ';J7
M-,I10!)FEI@IU #J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DI:
M2@ S3<T&FF@!=U&ZF&B@"0&ES48IXH =2TE+0 4444 )2&G44 ,(IN*DQ1B@
M"/;2XI^*,4 -Q3J,4M !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4E+10 TTTBGT8H CQ28J3%&* & 4X"G8HQ0 4M%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!'NI<U%FES0!)FES48-.!
MH ?2TT4M "T444 %%%% !1110 4E!I#0 9I,TA--)H ?FC-1YI0: ),TM,!I
MPH =124M !1110 E)F@TA- !FC-,)I,T 29I<U&#2@T 24M-%+0 M%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M %6E%%% "BGBBB@!PIU%% "T444 %%%% !1110 AI#110 PTTT44 -I1110
M\4X444 .I:** "BBB@!IIAHHH ::;110 HIPHHH >*=110 M%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
